New Bill Regulating Assisted Human Reproduction in Ireland: What It Means for Ireland

ReproMed Blog
ReproMed Blog

Home > Blog

New Bill Regulating Assisted Human Reproduction: What It Means for Ireland

Ireland is on the brink of a significant change in the realm of Assisted Human Reproduction (AHR) with the introduction of a new bill approved yesterday. This proposed law aims to regulate treatments and procedures related to surrogacy and fertility, both within the country and for certain individuals connected to Ireland but residing abroad. This comprehensive legislation is poised to bring clarity, safety, and enhanced rights to both patients and AHR professionals. Here’s a first-hand breakdown of what this bill means for us in Ireland. 

Understanding the new AHR bill 

The bill, officially known as an Act to regulate the provision of any treatment or procedure for surrogacy and fertility, addresses several key areas:

Regulation of AHR treatments

The bill mandates that all AHR treatments involving gametes (eggs and sperm), embryos, or reproductive tissues must be licensed. These treatments aim to help establish or preserve the possibility of pregnancy and include surrogacy services. 


Licensing authority

A new regulatory body, the Assisted Human Reproduction Regulatory Authority (AHRRA), will be established to oversee the licensing process. No person or clinic can provide AHR treatments without a license from the AHRRA. 


Research regulations

The bill also covers research involving embryos and stem cells, collectively known as ESC research. Similar to AHR treatments, ESC research will require a license from the AHRRA to ensure ethical and safe practices. 


Rights for individuals born via AHR

The bill ensures that individuals born as a result of AHR treatments have the right to access information about their genetic origins. This provision aims to promote transparency and the well-being of individuals conceived through these methods. 


Enforcement and penalties

The AHRRA will have the authority to enforce regulations, including the suspension or revocation of licenses. Penalties for non-compliance may include fines and other sanctions. 


Impact on Ireland’s Patients


Enhanced safety and ethical standards

By requiring licenses for all AHR treatments and ESC research, the bill ensures that only qualified professionals provide these services. This regulation will help maintain high ethical standards and protect the well-being of patients and donors. 


Improved access to information

Individuals born through AHR treatments will have the legal right to learn about their genetic background. This transparency can foster a sense of identity and well-being for those conceived via these methods. 


Streamlined regulatory framework

The creation of the AHRRA will centralise the oversight of AHR services and research, making the regulatory process more efficient. This centralisation will likely improve compliance and enforcement of the new laws. 


Encouragement of ethical research

By regulating ESC research, the bill promotes ethical scientific advancements in the field of reproductive health. Researchers will have clear guidelines to follow, which can foster innovation while protecting human rights. 


Legal clarity for surrogacy and fertility services

The bill provides a clear legal framework for surrogacy and fertility treatments, which can reduce legal ambiguities and disputes. Couples and individuals seeking these services will have more confidence in the legal processes involved. 


ReproMed’s commitment to compliance and quality care

ReproMed, one of Ireland’s leading fertility clinics, is committed to complying with any new regulations to ensure the highest standards of safety and quality care. We are delighted to see this legislation being implemented in our country, as it represents a significant advance towards safeguarding human rights and promoting ethical practices in AHR. This bill will certainly help us continue to provide exceptional care to our patients while adhering to the new standards set forth by the AHRRA.